Tissue Sealants Market Outlook 2031
The global tissue sealants market size was valued at USD 2.32 Billion in 2022 and is projected to reach USD 4.27 Billion by 2031, expanding at a CAGR of 7% during the forecast period, 2023–2031. The growth of the market is attributed to the increasing incidences of cardiovascular problems, sports related injuries, and growing trauma conditions that require surgical procedures.
Tissue sealants are utilized to inhibit excess loss of fluids during the surgery from a particular part of the body. The tissue sealants are effective protective barrier due to its properties such as cohesive strength and adhesive property, which result in the action of tissue sealants at surgical sites.
The stable technological advancement in the healthcare sector is the vital aspect for the growth of the market in the near future. The surging surgeries cases around the world. According to the Organization for Economic Co-operation and Development (OECD) report, the figure of surgeries completed was 378,450 in 2013, which inclined in number to 396,220 during 2017 in Canada.
In France, the number of surgeries completed were 773,308 in 2014 and the number had surged to 863,840 in 2017. Also, several European countries such as Italy, Spain, and the Netherlands have also increased the amount of surgeries substantially over the recent years.
Several advantages of tissue sealants include easy management anti coagulated patients, ease to handle, improved visualization, save operative time, and avoid leakage of lap procedures.
Moreover, certain advantages including minimization of blood loss, reduce or avoid transfusion, provides flexibility to patients, prevents alteration of lap procedure, quick healing, reduce post operation drainage, and its low rate of rejection present key aspects for the massive use of the tissue sealants. The product has its wide application in procedures such as otolaryngology, urological, pulmonary, neurological, colorectal, and cardiovascular surgeries.
Tissue Sealants Market Trends, Drivers, Restraints, and Opportunities
- Rising research & development activities in the field as well as heavy investments by the major market players are boosting the market growth during the forecast period.
- Increasing number of the geriatric population around the globe is also propelling the market in the coming future as the old-age population is at greater risk of several illness requiring to undergo surgeries.
- Technological advancements as well as highly advanced techniques for the surgeries are driving the market in the coming years.
- Strict regulation in the approval of the products along with expensive cost of the products are proving to be major hindrances that can restrict the market expansion.
- Increasing number of surgeries, development of technical factors, and increasing funding in the market are offering huge opportunities for the market expansion in the long run.
Scope of Tissue Sealants Market Report
The report on the global tissue sealants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Tissue Sealants Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Products (Synthetic Tissue Sealants [Polyethylene Glycol Tissue Sealants and Cyanoacrylate-based Tissue Sealants] and Natural Tissue Sealants [Fibrin Tissue Sealants, Collagen-based Natural Tissue Sealants, and Albumin Tissue Sealants])
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Genzyme Corporation; Hemacure; Cohesion Technologies, Inc.; Integra LifeSciences Corporation; C.R. Bard, Inc.; and Johnson & Johnson Services, Inc.
|
Tissue Sealants Market Segment Insights
Products Segment Analysis
Based on products, the global tissue sealants market is bifurcated into natural tissue sealants and synthetic tissue sealants. The natural tissue segment is further segregated into collagen-based natural tissue sealants, fibrin tissue sealants, and albumin tissue sealants.
Meanwhile, the synthetic segment is sub-divided into cyanoacrylate and polyethylene glycol. The natural tissue sealants segment is expected to grow at a rapid pace during the forecast period attributed to the factors inhibits leakages, being cost effective, and short duration.
Moreover, natural tissues cause to offer the natural process of clotting without the use of any drugs or artificial substance. On the other hand, the synthetic segment is anticipated to exhibit substantial growth in the coming years as it provides effective results as well as takes less time to produce results.
Regional Outlook
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the projected period owing to the well-developed healthcare facilities, high investments by the market players, and large patient population in the region.
Moreover, favorable government programs for the surgeries management is expected to boost the regional market growth in the coming years. Meanwhile, the Latin America market is expected to represent considerable growth in the coming years due to the high investment, growing interest of public and private sector in the market, and high population in the region.
The Asia Pacific market, however, has a massive potential to bolster its market during the forecast period as it hold a huge population base along with developing healthcare facilities in the region.
Segments
The global tissue sealants market has been segmented on the basis of
Products
- Synthetic Tissue Sealants
- Polyethylene Glycol Tissue Sealants
- Cyanoacrylate-based Tissue Sealants
- Natural Tissue Sealants
- Fibrin Tissue Sealants
- Collagen-based Natural Tissue Sealants
- Albumin Tissue Sealants
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
The key market players in the global tissue sealants market are Integra LifeSciences Corporation; Genzyme Corporation; Hemacure; Cohesion Technologies, Inc.; C.R. Bard, Inc.; and Johnson & Johnson Services, Inc.